Sabaa announces signing EGP 135 mn hep C treatment agreement with national insurance

Pharma producer Sabaa International Company announced it signed an agreement with the national health insurance and the Liver Institute to supply 450k packets of its hepatitis C treatment Sofoheb, according to an EGX disclosure. The agreement is worth EGP 135 mn approximately and lasts until mid-2018. Sabaa expects the agreement to contribute at least EGP 12 mn to its income.